SHL Telemedicine Ltd. (SHLT)
NASDAQ: SHLT
· Real-Time Price · USD
2.05
0.00 (0.00%)
At close: Apr 02, 2025, 10:51 AM
SHL Telemedicine Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 13.93M | 13.93M | 14.04M | 14.04M | 28.71M | 14.5M | 27.95M | 14.05M | 30.77M | 15.45M | 14.28M | 14.28M | 10.52M | 10.52M |
Cost of Revenue | 7.39M | 7.39M | 7.79M | 7.79M | 16.06M | 8.11M | 15.71M | 7.9M | 15.95M | 8.01M | 7.43M | 7.43M | 5.07M | 5.07M |
Gross Profit | 6.55M | 6.55M | 6.24M | 6.24M | 12.65M | 6.39M | 12.23M | 6.15M | 14.83M | 7.44M | 6.85M | 6.85M | 5.45M | 5.45M |
Operating Income | -1.96M | -1.96M | -2.28M | -1.66M | -3.88M | -2.23M | -3.8M | -2.07M | -922.2K | -508.5K | 169K | 169K | -63.5K | -63.5K |
Interest Income | n/a | n/a | 1.64M | 1.64M | 4.42M | 1.52M | 6.31M | 970K | 668K | 668K | 4.72M | 4.72M | 4.79M | 4.79M |
Pretax Income | -1.71M | -1.71M | -2.27M | -2.27M | -1.4M | -707K | 987.61K | 496.5K | 317.69K | 159.5K | -1.88M | -1.88M | -4.86M | -4.86M |
Net Income | -2M | -2M | -2.42M | -2.42M | -2.19M | -1.11M | -100.45K | -50.5K | 24.9K | 12.5K | -1.91M | -1.91M | -5.14M | -5.14M |
Selling & General & Admin | 7M | 7M | 6.25M | 6.25M | 14.16M | 7.15M | 13.97M | 7.03M | 14.04M | 7.05M | 6.19M | 6.19M | 4.59M | 4.59M |
Research & Development | 1.3M | 1.3M | 1.44M | 1.44M | 2.36M | 1.19M | 2.06M | 1.04M | 1.71M | 857.5K | 643K | 643K | 849.5K | 849.5K |
Other Expenses | n/a | 207.5K | 834.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 8.51M | 8.51M | 8.52M | 6.88M | 16.53M | 8.61M | 16.04M | 4.68M | 15.75M | 7.95M | 13.44M | 13.44M | 5.51M | 5.51M |
Interest Expense | n/a | n/a | n/a | n/a | 1.41M | n/a | 1.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 2.79M | 2.79M | 2.48M | 2.48M | 2.81M | 2.81M | 3.11M | 3.11M | 2.59M | 2.59M | 2.53M | 2.53M | 2.19M | 2.19M |
Cost & Expenses | 15.9M | 15.9M | 16.31M | 14.67M | 32.59M | 16.73M | 31.75M | 12.58M | 31.7M | 15.96M | 20.87M | 20.87M | 10.58M | 10.58M |
Income Tax Expense | 232.5K | 232.5K | 92.5K | 92.5K | 698.88K | 353K | 840.41K | 422.5K | 250.97K | 126K | 55.5K | 55.5K | 283K | 283K |
Shares Outstanding (Basic) | 16.67M | 16.67M | 12.21M | 12.21M | 15.84M | 15.84M | 14.54M | 14.53M | 14.52M | 14.52M | 14.15M | 14.38M | 13.71M | 13.71M |
Shares Outstanding (Diluted) | 16.67M | 16.67M | 16.7M | 16.7M | 15.84M | 15.84M | 14.54M | 14.68M | 14.52M | 14.52M | 14.38M | 14.38M | 13.71M | 13.71M |
EPS (Basic) | -0.12 | -0.12 | -0.2 | -0.2 | -0.14 | -0.07 | -0.01 | -0.00 | 0.00 | 0.00 | -0.14 | -0.13 | -0.38 | -0.38 |
EPS (Diluted) | -0.12 | -0.12 | -0.14 | -0.14 | -0.14 | -0.07 | -0.01 | -0.00 | 0.00 | 0.00 | -0.13 | -0.13 | -0.38 | -0.38 |
EBITDA | -103.5K | -103.5K | -1.07M | -680.33K | 3.49M | -469K | 5.89M | -1.05M | 4.86M | 1.2M | 2.14M | 891.83K | 1.06M | 1.06M |
EBIT | -1.96M | -1.96M | -4.2M | -1.66M | -2.23M | -2.23M | -2.07M | -2.07M | -508.5K | -508.5K | 169K | 169K | -63.5K | -63.5K |
Depreciation & Amortization | 1.86M | 1.86M | 592.25K | 980.17K | 3.48M | 1.76M | 3.7M | 1.02M | 3.4M | 1.71M | 1.97M | 722.83K | 1.12M | 1.12M |